FAQs Archive | Page 8 of 8 | OM1 outcomes & advanced analytics

Does OM1 apply inclusion/exclusion of specific therapies according to %BSA values that would cause only certain therapies to be included by BSA value?

June 2, 2023September 13, 2023

OM1 does not apply inclusion or exclusion selection criteria for patients specific to their %BSA values and targeted therapies. Further, our Managing Director for Dermatology confirmed that the uniformity of BSA values across therapies observed in the data is reflected in clinical practice. Once a patient qualifies for a biologic (>8% BSA or special areas)[…]

Have you published your eEDSS model?

June 2, 2023July 20, 2023

Yes, please see our peer reviewed publication: Validation of a machine learning approach to estimate expanded disability status scale scores for multiple sclerosis

How can we assess disease progression in the Multiple Sclerosis dataset? Is EDSS available?

June 2, 2023July 20, 2023

OM1 captures EDSS where recorded by the provider. However, while the EDSS is commonly performed in clinical trials, it is not part of routine clinical practice. To increase the number of EDSS scores available for analysis, OM1 has generated an estimated EDSS score (eEDSS), which has increased the number of patients with an EDSS by[…]